Clone
New York, United States
Humanoid Robots · Founded 2021 · Series B
Clone develops lifelike bipedal androids with advanced musculoskeletal systems and synthetic human capabilities. The company is building humanoid companions for both individuals and businesses, with its Clone Alpha platform serving as the primary consumer offering. Clone's breakthrough innovation is its human-level robotic hand, now produced cost-effectively at approximately $2,800 per unit. The company is also developing Neo, an advanced android platform representing its vision for the future of humanoid robotics. Clone has raised over $23M in total funding and operates development facilities in New York and Poland.
Visit website- Based in
- New York, United States
- Founded
- 2021
- Builds
- Humanoid Robots
- Industries
- Consumer
- Stage
- Series B
- Team
- 40 to 55 people
- Funding raised
- $23.1M
- Open roles
- None listed today